Submitted by Anonymous (not verified) on 21 August 2025 - 13:51
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 3, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 3, Status: Authorised